<DOC>
	<DOCNO>NCT00320268</DOCNO>
	<brief_summary>This study evaluate ( SEROQUEL® ) quetiapine sustained-release efficacious safe treatment patient MDD .</brief_summary>
	<brief_title>Safety &amp; Efficacy Study Quetiapine Fumarate ( SEROQUEL® ) v . Placebo Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patient document clinical diagnosis Major Depressive Disorder . Be able understand comply requirement study . Able understand provide write informed consent Patients ( female ) must pregnant lactate Current past diagnosis stroke transient ischemic attack ( TIA ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>MDD</keyword>
	<keyword>Quetiapine fumarate , sustain release</keyword>
	<keyword>Depression</keyword>
</DOC>